Market Overview

UPDATE: Morgan Stanley Cuts PT to $42 on MetLife Following Guidance

Related MET
Credit Suisse's Top 10 Financial Stocks
7 Stocks You Should Be Watching Today
Marc Lasry: 'U.S. Economy Is Doing Great... The Best Place To Invest Is The U.S.' (Seeking Alpha)

Morgan Stanley reiterated its Overweight rating on MetLife (NYSE: MET) but lowered its price target from $44 to $42.

Morgan Stanley noted, "MetLife's guidance was modestly disappointing, with both EPS and capital expectations running somewhat below our expectations. That said, their guidance is typically conservative (they typically hit at least the high end), and even with lowered numbers, the valuation multiple on stock is very low."

MetLife closed at $33.61 on Wednesday.

Latest Ratings for MET

Oct 2015JP MorganMaintainsOverweight
Jul 2015Deutsche BankMaintainsBuy
Jul 2015CitigroupMaintainsBuy

View More Analyst Ratings for MET
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (MET)

View Comments and Join the Discussion!

Get Benzinga's Newsletters